Our NewsOctober 7, 2023World-Leading VC Qiming Venture Partners Invests in Complete Omics to Accelerate Clinical Proteomics
Our NewsJune 27, 2023Complete Omics Founder Dr. Qing Wang Featured on Wharton Business School Website
Our NewsJanuary 29, 2022Complete Omics Establishes a New Immunotherapy Target Class: HERV-Derived Neoantigens
Our Insight, Our NewsApril 3, 2021Complete Omics neoantigen detection platform reported by numerous media
Our NewsMarch 31, 2021Complete Omics Neoantigen Platform Powers Landmark Breakthroughs Published in Science and Science Immunology
Our NewsOctober 31, 2019GenomeWeb Highlights Complete Omics Founder’s Breakthrough Neoantigen Detection Platform for Precision Cancer Immunotherapy
Our Insight, Our NewsOctober 10, 2019Complete Omics Founded to Redefine Precision Medicine Through Clinical Proteomics
